The outcomes of patients with ESRD and ANCA-associated vasculitis in Australia and New Zealand.
about
Recent advances in anti-neutrophil cytoplasmic antibody-associated vasculitisGuidelines on the Use of Therapeutic Apheresis in Clinical Practice-Evidence-Based Approach from the Writing Committee of the American Society for Apheresis: The Seventh Special Issue.Survival of patients with ANCA-associated vasculitis on chronic dialysis: data from the French REIN registry from 2002 to 2011.Improved prognosis in Norwegian patients with glomerulonephritis associated with anti-neutrophil cytoplasmic antibodies.Patient characteristics and outcomes by GN subtype in ESRD.Renal transplantation in anti-neutrophil cytoplasmic antibody-associated vasculitis.The long-term outcomes of systemic vasculitis.A retrospective study on the outcomes of MPO-ANCA-associated vasculitis in dialysis-dependent patients.The kidneys and ANCA-associated vasculitis: from pathogenesis to diagnosis.Conventional induction and maintenance treatment of Antineutrophil cytoplasmic antibodies-associated vasculitis - still of value for our patients?Outcome of kidney transplantation in pediatric patients with ANCA-associated glomerulonephritis: a single-center experience.Establishing the feasibility of face transplantation in Granulomatosis with Polyangiitis (Wegener's).Kidney Transplantation Outcomes across GN Subtypes in the United States.Relevance of ANCA positivity at the time of renal transplantation in ANCA associated vasculitis.End-stage renal disease in ANCA-associated vasculitis.Outcome of Patients With Small Vessel Vasculitis After Renal Transplantation: National Database Analysis.
P2860
Q26751357-E1F6C099-CF16-4422-8092-3B87FD4B1FA7Q30276550-AC1DB49F-83D1-4B62-885B-4E49B387DB15Q30764638-114B7A3B-5CD8-45C7-B260-4C83F1B1A18FQ35212086-D73C022D-C950-4B3A-9FE3-98093EC655B6Q35817064-E78F4F44-21E1-45F6-A6D9-D732DA40C528Q38260987-34831A76-C7D1-4E84-87BE-761A3058BA1DQ38324168-5979F74C-4F71-4D81-A213-13B9F295B905Q38475970-9ACD9843-C1AF-469C-B754-CA02A4E51A12Q38512570-62348243-C591-4457-8F2F-B48DC43FE717Q38543360-FAE7F435-310B-42EC-84DD-1EADE0AAA457Q38647588-1F3BC177-A6BC-41A6-8E11-52824559A8E3Q38733089-8C7726D1-6919-4E7A-A34A-0C9C42ABADA5Q38840225-D19A2E88-B0D1-483C-A6F8-753DFAC556E5Q47945583-063ABDE6-2A32-4A7A-A94D-F9C29A34C9EAQ53513595-0CAE8970-B45C-4EDF-8A95-0CF9D7036EC7Q54987113-06616016-EE47-42E6-AF79-308FAB93D2C2
P2860
The outcomes of patients with ESRD and ANCA-associated vasculitis in Australia and New Zealand.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
2013年论文
@zh
2013年论文
@zh-cn
name
The outcomes of patients with ...... in Australia and New Zealand.
@ast
The outcomes of patients with ...... in Australia and New Zealand.
@en
type
label
The outcomes of patients with ...... in Australia and New Zealand.
@ast
The outcomes of patients with ...... in Australia and New Zealand.
@en
prefLabel
The outcomes of patients with ...... in Australia and New Zealand.
@ast
The outcomes of patients with ...... in Australia and New Zealand.
@en
P2093
P2860
P50
P356
P1476
The outcomes of patients with ...... s in Australia and New Zealand
@en
P2093
Chen Au Peh
David W Johnson
Fiona G Brown
Neil Boudville
Philip A Clayton
Scott B Campbell
P2860
P304
P356
10.2215/CJN.08770812
P577
2013-01-24T00:00:00Z